Results 131 to 140 of about 5,106 (179)
Some of the next articles are maybe not open access.
Antifibrinolytic Agents in the Management of Traumatic Hyphema
Archives of Ophthalmology, 1983Clinical confusion often exists when therapeutic alternatives for a particular disease have not been rigorously compared. This problem is typical of the series of clinical decisions required in the management of traumatic hyphema and its complications. For example, should the patient (1) be admitted to the hospital, (2) undergo bilateral or unilateral ...
openaire +2 more sources
Monitoring the Effect of Antifibrinolytic Agents and Thrombolytic Agents
Abstract Clinical conditions that may require the use of an antifibrinolytic agent (tranexamic acid or aminocaproic acid) to control fibrinolysis-associated bleeding are listed. Tests to monitor antifibrinolytic therapy are unavailable in most laboratories.Gene Gulati +2 more
openaire +1 more source
Molecular imaging in oncology: Current impact and future directions
Ca-A Cancer Journal for Clinicians, 2022Steven P Rowe, Martin G Pomper
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Antifibrinolytic Agents in Traumatic Hemorrhage
Annals of Epidemiology, 2006openaire +2 more sources
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Ca-A Cancer Journal for Clinicians, 2019Marsela Braunstein +2 more
exaly